A retrospective data analysis of the impact of the New York triplicate prescription program on benzodiazepine use in medicaid patients with chronic psychiatric and neurologic disorders.

Source:http://linkedlifedata.com/resource/pubmed/id/15038954

Download in:

View as

General Info

PMID
15038954